Researchers show that cells without HOXA5 have an increased capacity to renew themselves and are more invasive than normal breast cells.
The variant was discovered through the analysis of whole genome and clinical data from across the population of Iceland.
The researchers plan to use their mouse model to better understand how ketamine functions to develop safer alternatives.
The technology could bring the option of an islet transplant to thousands more patients with type 1 diabetes.
Researchers have tried to address this problem in two ways, each with varying degrees of success.
The result is likely to surprise many skeptics who did not believe insulin could be delivered orally.
The new drug to treat MRSA combines traditional Food and Drug Administration-approved antibiotics with the polymer BPEI.
Currently, no single vaccine can give immunity against even a majority of circulating flu virus strains.
Over the past decade, new strategies in peptide design have launched a wave of peptide therapeutics. Currently, there are approximately 140 peptide therapeutics in clinical development with over 500 in preclinical development, and the commercial market for novel innovative peptide therapeutics is expected to increase to $17.0 billion by 2018.
A new kind of drug for the deadliest form of skin cancer helped some patients survive for at least three years, a study shows.
Findings to be presented at the meeting will also include additional research to explore biomarkers that may help predict outcomes with Opdivo.
The drug is expected to bring around $2.5 billion in annual sales by 2020.
Scientists are planning a major study of an experimental HIV vaccine in South Africa later this year.
Over the past 15 years, deaths caused by heroin and prescription opioid overdoses have quadrupled despite the existence of a highly effective antidote.